227 related articles for article (PubMed ID: 27147563)
1. Integrative analysis reveals clinical phenotypes and oncogenic potentials of long non-coding RNAs across 15 cancer types.
Wang ZL; Li B; Piccolo SR; Zhang XQ; Li JH; Zhou H; Yang JH; Qu LH
Oncotarget; 2016 Jun; 7(23):35044-55. PubMed ID: 27147563
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
Arnes L; Liu Z; Wang J; Maurer C; Sagalovskiy I; Sanchez-Martin M; Bommakanti N; Garofalo DC; Balderes DA; Sussel L; Olive KP; Rabadan R
Gut; 2019 Mar; 68(3):499-511. PubMed ID: 29440233
[TBL] [Abstract][Full Text] [Related]
3. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.
Du Z; Fei T; Verhaak RG; Su Z; Zhang Y; Brown M; Chen Y; Liu XS
Nat Struct Mol Biol; 2013 Jul; 20(7):908-13. PubMed ID: 23728290
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J
J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701
[TBL] [Abstract][Full Text] [Related]
5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
6. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer.
Liu W; Zhang Y; Chen M; Shi L; Xu L; Zou X
Cancer Med; 2018 Aug; 7(8):4181-4189. PubMed ID: 29926523
[TBL] [Abstract][Full Text] [Related]
8. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
9. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
10. Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
Jiang B; Hailong S; Yuan J; Zhao H; Xia W; Zha Z; Bin W; Liu Z
Biomed Pharmacother; 2018 Dec; 108():500-507. PubMed ID: 30243082
[TBL] [Abstract][Full Text] [Related]
11. A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.
Ren W; Zhang J; Li W; Li Z; Hu S; Suo J; Ying X
Med Sci Monit; 2016 Oct; 22():3647-3657. PubMed ID: 27727196
[TBL] [Abstract][Full Text] [Related]
12. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.
Esposti DD; Hernandez-Vargas H; Voegele C; Fernandez-Jimenez N; Forey N; Bancel B; Le Calvez-Kelm F; McKay J; Merle P; Herceg Z
Oncotarget; 2016 May; 7(22):31862-77. PubMed ID: 26887054
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Li M; Long S; Hu J; Wang Z; Geng C; Ou S
Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
[TBL] [Abstract][Full Text] [Related]
18. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
